ANT 3273
Alternative Names: ANT-3273Latest Information Update: 31 Mar 2023
At a glance
- Originator Antabio
- Class Antibacterials
- Mechanism of Action Pancreatic elastase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Bronchiectasis; Chronic obstructive pulmonary disease; Cystic fibrosis
Most Recent Events
- 04 Sep 2022 Pharmacodynamics data from a preclinical trial in Respiratory diseases presented at the 32nd Annual Congress of the European Respiratory Society (ERS-2022)
- 06 Jan 2022 Preclinical trials in Bronchiectasis in France (Inhalation) (Antabio pipeline, Jnauary 2023)
- 06 Jan 2022 Preclinical trials in Chronic obstructive pulmonary disease in France (Inhalation) (Antabio pipeline, Jnauary 2023)